News

The price tag of this acquisition suggests that the value of genetic data is declining. Back in 2018, the drug company GSK ...
Tarrytown-based Regeneron Pharmaceuticals, Inc. has announced it has been named the successful bidder in the bankruptcy ...
To acquire Personal Genome Service, Total Health and Research Services business lines, and its Biobank and associated assets.
Regeneron, a biotech company, will acquire 23andMe for $256 million and vowed to comply with the genetic testing company's ...
Me, known for its at-home DNA testing kits, is expected to be obtained by its highest bidder following a bankruptcy auction ...
Regeneron Pharmaceuticals is set to acquire substantially all assets of 23andMe for $256 million. The deal is expected to ...
Regeneron Pharmaceuticals will acquire embattled DNA testing company 23andMe in a $256 million court-supervised sale, ...